Renal Tubule Angiotensin II Type 1 Receptor–Associated Protein Promotes Natriuresis and Inhibits Salt‐Sensitive Blood Pressure Elevation
-
- Hiromichi Wakui
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Kazushi Uneda
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Kouichi Tamura
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Masato Ohsawa
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Kengo Azushima
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Ryu Kobayashi
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Kohji Ohki
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Toru Dejima
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Tomohiko Kanaoka
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Yuko Tsurumi‐Ikeya
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Miyuki Matsuda
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Kotaro Haruhara
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Akira Nishiyama
- Department of Pharmacology, Kagawa University School of Medicine, Kagawa, Japan
-
- Machiko Yabana
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Tetsuya Fujikawa
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Akio Yamashita
- Department of Molecular Biology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
-
- Satoshi Umemura
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
書誌事項
- 公開日
- 2015-03-10
- 資源種別
- journal article
- DOI
-
- 10.1161/jaha.114.001594
- 公開者
- Ovid Technologies (Wolters Kluwer Health)
説明
<jats:sec xml:lang="en"> <jats:title>Background</jats:title> <jats:p xml:lang="en"> Angiotensin <jats:styled-content style="fixed-case">II</jats:styled-content> type 1 receptor ( <jats:styled-content style="fixed-case">AT</jats:styled-content> 1R)–associated protein ( <jats:styled-content style="fixed-case">ATRAP;</jats:styled-content> <jats:italic>Agtrap</jats:italic> gene) promotes <jats:styled-content style="fixed-case">AT</jats:styled-content> 1R internalization along with suppression of pathological <jats:styled-content style="fixed-case">AT</jats:styled-content> 1R activation. In this study, we examined whether enhancement of <jats:styled-content style="fixed-case">ATRAP</jats:styled-content> in the renal distal tubules affects sodium handling and blood pressure regulation in response to high salt ( <jats:styled-content style="fixed-case">HS</jats:styled-content> ) loading, using <jats:styled-content style="fixed-case">ATRAP</jats:styled-content> transgenic mice on a salt‐sensitive C57 <jats:styled-content style="fixed-case">BL</jats:styled-content> /6J background. </jats:p> </jats:sec> <jats:sec xml:lang="en"> <jats:title>Methods and Results</jats:title> <jats:p xml:lang="en"> Renal <jats:styled-content style="fixed-case">ATRAP</jats:styled-content> transgenic ( <jats:styled-content style="fixed-case">rATRAP</jats:styled-content> ‐Tg) mice, which exhibit renal tubule–dominant <jats:styled-content style="fixed-case">ATRAP</jats:styled-content> enhancement, and their wild‐type littermate C57 <jats:styled-content style="fixed-case">BL</jats:styled-content> /6J mice on a normal salt diet (0.3% NaCl) at baseline were subjected to dietary <jats:styled-content style="fixed-case">HS</jats:styled-content> loading (4% NaCl) for 7 days. In <jats:styled-content style="fixed-case">rATRAP</jats:styled-content> ‐Tg mice, the dietary <jats:styled-content style="fixed-case">HS</jats:styled-content> loading–mediated blood pressure elevation was suppressed compared with wild‐type mice, despite similar baseline blood pressure. Although renal angiotensin <jats:styled-content style="fixed-case">II</jats:styled-content> level was comparable in <jats:styled-content style="fixed-case">rATRAP</jats:styled-content> ‐Tg and wild‐type mice with and without <jats:styled-content style="fixed-case">HS</jats:styled-content> loading, urinary sodium excretion in response to <jats:styled-content style="fixed-case">HS</jats:styled-content> loading was significantly enhanced in the <jats:styled-content style="fixed-case">rATRAP</jats:styled-content> ‐Tg mice. In addition, functional transport activity of the amiloride‐sensitive epithelial Na <jats:sup>+</jats:sup> channel was significantly decreased under saline volume–expanded conditions in <jats:styled-content style="fixed-case">rATRAP</jats:styled-content> ‐Tg mice compared with wild‐type mice, without any evident change in epithelial Na <jats:sup>+</jats:sup> channel protein expression. Plasma membrane <jats:styled-content style="fixed-case">AT</jats:styled-content> 1R expression in the kidney of <jats:styled-content style="fixed-case">rATRAP</jats:styled-content> ‐Tg mice was decreased compared with wild‐type mice. </jats:p> </jats:sec> <jats:sec xml:lang="en"> <jats:title>Conclusions</jats:title> <jats:p xml:lang="en"> These results demonstrated that distal tubule–dominant enhancement of <jats:styled-content style="fixed-case">ATRAP</jats:styled-content> inhibits pathological renal sodium reabsorption and blood pressure elevation in response to <jats:styled-content style="fixed-case">HS</jats:styled-content> loading. The findings suggest that <jats:styled-content style="fixed-case">ATRAP</jats:styled-content> ‐mediated modulation of sodium handling in renal distal tubules could be a target of interest in salt‐sensitive blood pressure regulation. </jats:p> </jats:sec>
収録刊行物
-
- Journal of the American Heart Association
-
Journal of the American Heart Association 4 (3), e001594-, 2015-03-10
Ovid Technologies (Wolters Kluwer Health)
- Tweet
キーワード
- Time Factors
- Angiotensin II
- Cell Membrane
- Natriuresis
- Blood Pressure
- Mice, Transgenic
- Receptor, Angiotensin, Type 1
- Amiloride
- Mice, Inbred C57BL
- Renin-Angiotensin System
- Disease Models, Animal
- Hypertension
- Epithelial Sodium Channel Blockers
- Animals
- Sodium Chloride, Dietary
- Epithelial Sodium Channels
- Kidney Tubules, Distal
- Biomarkers
- Original Research
- Adaptor Proteins, Signal Transducing
詳細情報 詳細情報について
-
- CRID
- 1360004236436864640
-
- ISSN
- 20479980
-
- PubMed
- 25792129
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE